Targeted cancer therapies
Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules ("molecular targets") that are involved in the growth, progression, and spread of cancer. Targeted cancer therapies are sometimes called "molecularly targeted drugs," "molecularly targeted therapies," "precision medicines," or similar names. Targeted therapies are currently the focus of much anticancer drug development. They are a cornerstone of precision medicine, a form of medicine that uses information about a person’s genes and proteins to prevent, diagnose, and treat disease. Many targeted cancer therapies have been approved by the Food and Drug Administration (FDA) to treat specific types of cancer.
- Hormone therapies
- Signal transduction inhibitors
- Gene expression modulators
- Apoptosis inducers
- Angiogenesis inhibitors
Related Conference of Targeted cancer therapies
Targeted cancer therapies Conference Speakers
Recommended Sessions
- Advances in Medical Imaging and Diagnosis
- Adaptive radiotherapy
- Angiogenesis Inhibitors
- Biomarkers
- Cancer Biopsy
- Cancer Drug Resistance & Cancer Vaccine
- Cancer Genomics
- Cancer Screening, Diagnosis & Prevention
- Chemotherapy
- Hormone Therapy
- Image guided radiotherapy
- Immunotherapy
- Medical Imaging
- Neuro interventional radiology
- Nuclear Medicine
- Positron Emission Tomography and Computed Tomography (PET-CT) Scans
- Precision Medicine
- Proton Therapy
- Radiation Therapy
- Radioimmunotherapy (RIT)
- Radiopharmaceutical Chemistry
- Stem Cell Transplant
- Targeted cancer therapies
- Tumor Microenvironment